Logo image of GCO

GENESCO INC (GCO) Stock Fundamental Analysis

NYSE:GCO - New York Stock Exchange, Inc. - US3715321028 - Common Stock - Currency: USD

22.96  -0.27 (-1.16%)

After market: 22.96 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GCO. GCO was compared to 122 industry peers in the Specialty Retail industry. While GCO seems to be doing ok healthwise, there are quite some concerns on its profitability. GCO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

GCO had positive earnings in the past year.
GCO had a positive operating cash flow in the past year.
In multiple years GCO reported negative net income over the last 5 years.
GCO had a positive operating cash flow in 4 of the past 5 years.
GCO Yearly Net Income VS EBIT VS OCF VS FCFGCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

GCO has a Return On Assets of -1.12%. This is comparable to the rest of the industry: GCO outperforms 41.80% of its industry peers.
With a Return On Equity value of -3.02%, GCO perfoms like the industry average, outperforming 49.18% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.53%, GCO is in line with its industry, outperforming 44.26% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for GCO is significantly below the industry average of 12.95%.
Industry RankSector Rank
ROA -1.12%
ROE -3.02%
ROIC 1.53%
ROA(3y)0.75%
ROA(5y)1.21%
ROE(3y)1.82%
ROE(5y)2.91%
ROIC(3y)3.2%
ROIC(5y)N/A
GCO Yearly ROA, ROE, ROICGCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

GCO's Operating Margin of 0.89% is in line compared to the rest of the industry. GCO outperforms 42.62% of its industry peers.
In the last couple of years the Operating Margin of GCO has declined.
With a decent Gross Margin value of 47.05%, GCO is doing good in the industry, outperforming 73.77% of the companies in the same industry.
GCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.89%
PM (TTM) N/A
GM 47.05%
OM growth 3Y-51.59%
OM growth 5Y-30.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.1%
GM growth 5Y-0.51%
GCO Yearly Profit, Operating, Gross MarginsGCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GCO is destroying value.
The number of shares outstanding for GCO has been reduced compared to 1 year ago.
Compared to 5 years ago, GCO has less shares outstanding
GCO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GCO Yearly Shares OutstandingGCO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
GCO Yearly Total Debt VS Total AssetsGCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

GCO has an Altman-Z score of 2.37. This is not the best score and indicates that GCO is in the grey zone with still only limited risk for bankruptcy at the moment.
GCO has a Altman-Z score (2.37) which is in line with its industry peers.
A Debt/Equity ratio of 0.22 indicates that GCO is not too dependend on debt financing.
GCO's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. GCO outperforms 62.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.37
ROIC/WACC0.15
WACC10.57%
GCO Yearly LT Debt VS Equity VS FCFGCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

GCO has a Current Ratio of 1.91. This is a normal value and indicates that GCO is financially healthy and should not expect problems in meeting its short term obligations.
GCO has a Current ratio of 1.91. This is amongst the best in the industry. GCO outperforms 81.15% of its industry peers.
A Quick Ratio of 0.55 indicates that GCO may have some problems paying its short term obligations.
With a Quick ratio value of 0.55, GCO perfoms like the industry average, outperforming 54.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 0.55
GCO Yearly Current Assets VS Current LiabilitesGCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

5

3. Growth

3.1 Past

GCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 371.43%, which is quite impressive.
GCO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.12% yearly.
Looking at the last year, GCO shows a small growth in Revenue. The Revenue has grown by 1.85% in the last year.
GCO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.14% yearly.
EPS 1Y (TTM)371.43%
EPS 3Y-50.35%
EPS 5Y-28.12%
EPS Q2Q%2.38%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y-1.35%
Revenue growth 5Y1.14%
Sales Q2Q%3.58%

3.2 Future

Based on estimates for the next years, GCO will show a very strong growth in Earnings Per Share. The EPS will grow by 43.84% on average per year.
The Revenue is expected to grow by 1.92% on average over the next years.
EPS Next Y62.96%
EPS Next 2Y49.26%
EPS Next 3Y43.84%
EPS Next 5YN/A
Revenue Next Year-0.17%
Revenue Next 2Y0.92%
Revenue Next 3Y1.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GCO Yearly Revenue VS EstimatesGCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
GCO Yearly EPS VS EstimatesGCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

GCO is valuated rather expensively with a Price/Earnings ratio of 23.19.
Compared to the rest of the industry, the Price/Earnings ratio of GCO indicates a somewhat cheap valuation: GCO is cheaper than 64.75% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.50. GCO is around the same levels.
The Price/Forward Earnings ratio is 10.96, which indicates a very decent valuation of GCO.
Based on the Price/Forward Earnings ratio, GCO is valued a bit cheaper than the industry average as 77.87% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, GCO is valued rather cheaply.
Industry RankSector Rank
PE 23.19
Fwd PE 10.96
GCO Price Earnings VS Forward Price EarningsGCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GCO indicates a rather cheap valuation: GCO is cheaper than 85.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.72
GCO Per share dataGCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GCO's earnings are expected to grow with 43.84% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y49.26%
EPS Next 3Y43.84%

0

5. Dividend

5.1 Amount

No dividends for GCO!.
Industry RankSector Rank
Dividend Yield N/A

GENESCO INC

NYSE:GCO (7/18/2025, 8:04:00 PM)

After market: 22.96 0 (0%)

22.96

-0.27 (-1.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-04 2025-06-04/bmo
Earnings (Next)09-04 2025-09-04/bmo
Inst Owners101.72%
Inst Owner Change-0.25%
Ins Owners7.83%
Ins Owner Change5.71%
Market Cap247.51M
Analysts48
Price Target24.99 (8.84%)
Short Float %14.31%
Short Ratio5.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.08%
Min EPS beat(2)-2.34%
Max EPS beat(2)0.18%
EPS beat(4)3
Avg EPS beat(4)21.84%
Min EPS beat(4)-2.34%
Max EPS beat(4)63.23%
EPS beat(8)5
Avg EPS beat(8)11.6%
EPS beat(12)8
Avg EPS beat(12)14.88%
EPS beat(16)12
Avg EPS beat(16)263.93%
Revenue beat(2)1
Avg Revenue beat(2)-2.29%
Min Revenue beat(2)-5.9%
Max Revenue beat(2)1.32%
Revenue beat(4)3
Avg Revenue beat(4)-0.36%
Min Revenue beat(4)-5.9%
Max Revenue beat(4)1.64%
Revenue beat(8)6
Avg Revenue beat(8)0.69%
Revenue beat(12)8
Avg Revenue beat(12)0.31%
Revenue beat(16)10
Avg Revenue beat(16)0.65%
PT rev (1m)4.26%
PT rev (3m)-9.26%
EPS NQ rev (1m)-62.07%
EPS NQ rev (3m)-61.72%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 23.19
Fwd PE 10.96
P/S 0.11
P/FCF N/A
P/OCF 12.02
P/B 0.47
P/tB 0.51
EV/EBITDA 4.72
EPS(TTM)0.99
EY4.31%
EPS(NY)2.09
Fwd EY9.12%
FCF(TTM)-3.07
FCFYN/A
OCF(TTM)1.91
OCFY8.32%
SpS217.2
BVpS48.44
TBVpS45.03
PEG (NY)0.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.12%
ROE -3.02%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.57%
ROICexgc 1.62%
OM 0.89%
PM (TTM) N/A
GM 47.05%
FCFM N/A
ROA(3y)0.75%
ROA(5y)1.21%
ROE(3y)1.82%
ROE(5y)2.91%
ROIC(3y)3.2%
ROIC(5y)N/A
ROICexc(3y)3.34%
ROICexc(5y)N/A
ROICexgc(3y)3.53%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y-55.02%
ROICexcg growth 5Y-26.41%
ROICexc growth 3Y-54.26%
ROICexc growth 5Y-24.94%
OM growth 3Y-51.59%
OM growth 5Y-30.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.1%
GM growth 5Y-0.51%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.55
Cap/Depr 101.96%
Cap/Sales 2.29%
Interest Coverage 4.68
Cash Conversion 28.03%
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 0.55
Altman-Z 2.37
F-Score4
WACC10.57%
ROIC/WACC0.15
Cap/Depr(3y)113.44%
Cap/Depr(5y)103.5%
Cap/Sales(3y)2.29%
Cap/Sales(5y)2.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)371.43%
EPS 3Y-50.35%
EPS 5Y-28.12%
EPS Q2Q%2.38%
EPS Next Y62.96%
EPS Next 2Y49.26%
EPS Next 3Y43.84%
EPS Next 5YN/A
Revenue 1Y (TTM)1.85%
Revenue growth 3Y-1.35%
Revenue growth 5Y1.14%
Sales Q2Q%3.58%
Revenue Next Year-0.17%
Revenue Next 2Y0.92%
Revenue Next 3Y1.92%
Revenue Next 5YN/A
EBIT growth 1Y160.08%
EBIT growth 3Y-52.25%
EBIT growth 5Y-29.24%
EBIT Next Year326.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.04%
FCF growth 3Y-36.89%
FCF growth 5Y-11.76%
OCF growth 1Y115.46%
OCF growth 3Y-28.45%
OCF growth 5Y-5.59%